GSK Opens $971 Million Offer To Increase Stake In India Unit To 75%
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline began a $971 million bid to take a 75% interest in its India subsidiary, up from its current 50.7% stake.